Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia
Abstract Background Xpert® MTB/RIF assay is currently used in Ethiopia for the rapid diagnosis of Mycobacterium tuberculosis (MTB) and mutations that confer Rifampicin resistance. Rifampicin resistance is determined based on any mutation in the 81 bp of rpoB gene using five overlapping probes repres...
Main Authors: | Ayinalem Alemu, Mengistu Tadesse, Getachew Seid, Helina Mollalign, Kirubel Eshetu, Waganeh Sinshaw, Yeshiwork Abebaw, Misikir Amare, Biniyam Dagne, Getu Diriba, Bazezew Yenew, Melak Getu, Betselot Zerihun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-020-4817-2 |
Similar Items
-
Effect of sputum quality and role of Xpert® MTB/RIF assay for detection of smear-negative pulmonary tuberculosis in same-day diagnosis strategy in Addis Ababa, Ethiopia
by: Waganeh Sinshaw, et al.
Published: (2022-08-01) -
Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia
by: Waganeh Sinshaw, et al.
Published: (2019-07-01) -
Xpert MTB/RIF Ultra Assay Using Stool: an Effective Solution for Bacilli Identification from Adult Pulmonary Tuberculosis Suspects without Expectorated Sputum
by: Xia Yu, et al.
Published: (2023-08-01) -
Diagnostic Performance of Xpert MTB/RIF Ultra Compared with Predecessor Test, Xpert MTB/RIF, in a Low TB Incidence Setting: a Retrospective Service Evaluation
by: Mary Mansfield, et al.
Published: (2022-06-01) -
Use of Xpert MTB/RIF for diagnosis of pediatric tuberculosis in Indonesia
by: Rina Triasih, et al.
Published: (2020-07-01)